Literature DB >> 11758700

Proprioception in somatoform disorders.

O B Scholz1, R Ott, H Sarnoch.   

Abstract

20 patients with somatoform disorders as defined by DSM-IV and 20 healthy controls were examined for their proprioception. Several psychophysiological theories of somatoform disorders suggest biased proprioceptive abilities. The primary question is, whether we may find an inaccurate myogen perception in somatization as suggested by the approach of Bischoff or a more precise proprioception as may be derived from concepts of a higher awareness of body reactions. Furthermore it is expected, that somatoform patients perceive their muscle tension more intensely than do healthy subjects. Proprioceptive abilities were tested using a visual EMG biofeedback task. Resulting objective data and subjective ratings were analyzed within a psychophysiological regression approach which allows one to estimate the reliability, precision and intensity of proprioception. Results revealed that somatoform subjects demonstrated a more precise but not a more intense perception of muscle tension than did healthy controls.

Entities:  

Mesh:

Year:  2001        PMID: 11758700     DOI: 10.1016/s0005-7967(00)00108-x

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  3 in total

1.  The Effects of a 3-Week Heartbeat Perception Training on Interoceptive Abilities.

Authors:  Christine Schillings; Georgios Karanassios; Niklas Schulte; Dana Schultchen; Olga Pollatos
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

2.  Interoceptive accuracy and bias in somatic symptom disorder, illness anxiety disorder, and functional syndromes: A systematic review and meta-analysis.

Authors:  Carolin Wolters; Alexander L Gerlach; Anna Pohl
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

Review 3.  Perspectives on the clinical significance of functional pain syndromes in children.

Authors:  Molly C Basch; Erika T Chow; Deirdre E Logan; Neil L Schechter; Laura E Simons
Journal:  J Pain Res       Date:  2015-10-07       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.